TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG ...
(Bloomberg) -- Creditors to US satellite television firm Dish Network told DirecTV’s attorneys that the current merger proposal that calls for them to take an almost $1.6 billion loss is ...
Three principal thyroid autoantigens are involved in AITD. These are thyroperoxidase (TPO), thyroglobulin (Tg) and the TSH receptor. Other autoantigens, such as the Sodium Iodide Symporter (NIS ...